title: Selected topics from the 38th annual meeting of the Infectious Diseases Society of America, September 7-10, 2000, New Orleans, Louisiana and selected topics from the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 17-20, 2000, Toronto, Ontario, Canada.
authors.forename: G M
authors.initials: GM
authors.lastname: Lucas
authors.forename: T R
authors.initials: TR
authors.lastname: Sterling
authors.forename: J G
authors.initials: JG
authors.lastname: Bartlett
authors.forename: J E
authors.initials: JE
authors.lastname: Gallant
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology* / Q000382:microbiology / Q000821:virology; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D017277:Drug Approval; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019380:Anti-HIV Agents; D000904:Antibiotics, Antitubercular; D018894:Reverse Transcriptase Inhibitors